Coverage
Pharma & biotech
KOLs, former regulators, and clinical investigators who've been inside the therapeutic area you're studying, not adjacent to it.
Expert types
Common use cases
Pipeline & mechanism diligence
Validate a therapeutic mechanism or competitive pipeline read with practicing specialists in the relevant indication.
Regulatory pathway assessment
Get a former reviewer's perspective on approval strategy, trial design, or likely agency questions.
Launch readiness
Stress-test commercial and access assumptions with brand leads who've run comparable launches.
Competitive positioning
Understand how prescribers actually weigh your asset against the standard of care.
Questions we help answer
- “How will oncologists actually sequence this drug relative to the current standard of care?”
- “What would make the FDA push back on this trial design, based on precedent?”
- “Is the KOL enthusiasm at conferences translating into real prescribing intent?”
- “What did the competitor's Phase 2 readout actually tell prescribers, versus what the press release said?”
In practice
An investor needed to know whether oncologists would really switch regimens on a competitor's Phase 2 readout, or whether the market was overreacting to a press release. We sourced three practicing oncologists across academic and community settings within three business days, scoped around prescribing behavior rather than trial mechanics, and came back with a split view by practice setting that looked nothing like the market's first reaction.
Composite example, illustrative only.
How we deliver this
Who this serves